{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:08:27Z","timestamp":1760058507184,"version":"build-2065373602"},"reference-count":33,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274346","7242256"],"award-info":[{"award-number":["82274346","7242256"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["82274346","7242256"],"award-info":[{"award-number":["82274346","7242256"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CIMB"],"abstract":"<jats:p>Myelodysplastic syndrome (MDS) is a heterogeneous myeloid clonal disorder that represents a significant threat to human health. As2S2, a natural compound, has been shown to exert therapeutic effects on various malignant tumors, including acute myeloid leukemia (AML), breast cancer, and osteosarcoma, based on extensive clinical experience. In this study, we investigated the mechanism by which As2S2 inhibits the proliferation of the myelodysplastic syndrome (MDS) SKM-1 cell line. Our findings revealed that As2S2 inhibited the proliferation of SKM-1 cells in a time- and dose-dependent manner. Flow cytometry, protein immunoblotting, and real-time fluorescence quantitative PCR analyses demonstrated that As2S2 promotes the phosphorylation of P38 MAPK, thereby activating the MAPK signaling pathway. Additionally, it promotes apoptosis by increasing the BAX\/Bcl-2 ratio and induces S-phase arrest through the downregulation of the cell cycle-related protein cyclin A2. Further studies demonstrated that As2S2-treated cells exhibited ROS accumulation under fluorescence microscopy, along with activation of the P38 MAPK signaling pathway, increased apoptosis, and S-phase arrest in the cell cycle. This process could be partially reversed by the ROS inhibitor N-acetylcysteine. Therefore, the results of the present study suggest that As2S2 induces ROS accumulation in SKM-1 cells, which contributes to the activation of the P38 MAPK signaling pathway, promoting apoptosis and S-phase arrest in the cell cycle. Additionally, As2S2 may serve as a potent therapeutic agent for the treatment of myelodysplastic syndromes, with ROS acting as one of the key therapeutic targets.<\/jats:p>","DOI":"10.3390\/cimb47040253","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T20:43:17Z","timestamp":1745440997000},"page":"253","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["As2S2 Mediates the ROS\/P38 MAPK Signaling Pathway to Induce Apoptosis and S-Phase Arrest in Myelodysplastic Syndrome Cells"],"prefix":"10.3390","volume":"47","author":[{"given":"Pengjie","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7665-7580","authenticated-orcid":false,"given":"Li","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanxi","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengmei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonggang","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiupeng","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1056\/NEJMra1904794","article-title":"Myelodysplastic Syndromes","volume":"383","author":"Cazzola","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_2","first-page":"2391","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_3","first-page":"373","article-title":"Integrating patient-centered factors in the risk assessment of MDS","volume":"2019","author":"Buckstein","year":"2019","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jama.2022.14578","article-title":"Diagnosis and Treatment of Myelodysplastic Syndromes","volume":"328","author":"Sekeres","year":"2022","journal-title":"JAMA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1179\/1607845413Y.0000000138","article-title":"Arsenic disulfide-triggered apoptosis and erythroid differentiation in myelodysplastic syndrome and acute myeloid leukemia cell lines","volume":"19","author":"Hu","year":"2013","journal-title":"Hematology"},{"key":"ref_6","first-page":"1504","article-title":"Effects of Arsenic Disulfide Combined with Itraconazole on Proli-feration and Apoptosis and Hedgehog Pathway of Diffuse Large B-Cell Lymphoma Cells","volume":"29","author":"Wang","year":"2021","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/s11655-020-3254-9","article-title":"Oral Arsenic-Containing Qinghuang Powder: A Potential Drug for Myelodysplastic Syndromes","volume":"28","author":"Ming","year":"2020","journal-title":"Chin. J. Integr. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.freeradbiomed.2017.02.015","article-title":"Arsenic sulfide induces apoptosis and autophagy through the activation of ROS\/JNK and suppression of Akt\/mTOR signaling pathways in osteosarcoma","volume":"106","author":"Wang","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1142\/S0192415X19500599","article-title":"Arsenic Disulfide Combined with L-Buthionine-(S, R)-Sulfoximine Induces Synergistic Antitumor Effects in Two-Dimensional and Three-Dimensional Models of MCF-7 Breast Carcinoma Cells Am","volume":"47","author":"Zhao","year":"2019","journal-title":"J. Chin. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.2147\/DDDT.S239158","article-title":"Arsenic Disulfide Promoted Hypomethylation by Increasing DNA Methyltransferases Expression in Myelodysplastic Syndrome","volume":"14","author":"Zhou","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_11","first-page":"27","article-title":"Antitumor effects of arsenic disulfide on the viability, migratory ability, apoptosis and autophagy of breast cancer cells","volume":"41","author":"Zhao","year":"2018","journal-title":"Oncol. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Boese, A.C., and Kang, S. (2021). Mitochondrial metabolism-mediated redox regulation in cancer progression. Redox Biol., 42.","DOI":"10.1016\/j.redox.2021.101870"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","article-title":"Reactive oxygen species (ROS) as pleiotropic physiological signalling agents","volume":"21","author":"Sies","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Zhang, L., Wang, X., Cueto, R., Effi, C., Zhang, Y., Tan, H., Qin, X., Ji, Y., Yang, X., and Wang, H. (2019). Biochemical basis and metabolic interplay of redox regulation. Redox Biol., 26.","DOI":"10.1016\/j.redox.2019.101284"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2313366","DOI":"10.1080\/13510002.2024.2313366","article-title":"Jaceosidin induces apoptosis and inhibits migration in AGS gastric cancer cells by regulating ROS-mediated signaling pathways","volume":"29","author":"Liu","year":"2024","journal-title":"Redox Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3892\/mmr.2024.13330","article-title":"Exploring the therapeutic potential of rabdoternin E in lung cancer treatment: Targeting the ROS\/p38 MAPK\/JNK signaling pathway","volume":"30","author":"Jin","year":"2024","journal-title":"Mol. Med. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s11655-010-0506-0","article-title":"Application and assessment of Chinese arsenic drugs in treating malignant hematopathy in China","volume":"16","author":"Hu","year":"2010","journal-title":"Chin. J. Integr. Med."},{"key":"ref_18","first-page":"366","article-title":"Anticancer efficacies of arsenic disulfide through apoptosis induction, cell cycle arrest, and pro-survival signal inhibition in human breast cancer cells","volume":"8","author":"Zhao","year":"2018","journal-title":"Am. J. Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.2147\/DDDT.S89805","article-title":"Arsenic sulfide inhibits cell migration and invasion of gastric cancer in vitro and in vivo","volume":"9","author":"Chen","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"105656","DOI":"10.1016\/j.phrs.2021.105656","article-title":"Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8+ T cells","volume":"169","author":"Jiang","year":"2021","journal-title":"Pharmacol. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/35075107","article-title":"Initiation of a G2\/M checkpoint after ultraviolet radiation requires p38 kinase","volume":"411","author":"Bulavin","year":"2001","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nrc.2016.138","article-title":"Cell cycle proteins as promising targets in cancer therapy","volume":"17","author":"Otto","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00018-002-8510-y","article-title":"Cyclin A in cell cycle control and cancer","volume":"59","author":"Yam","year":"2002","journal-title":"Cell Mol. Life Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s11302-024-10021-2","article-title":"Molecular mechanisms of extracellular-ATP-mediated colorectal cancer progression: Implication of purinergic receptors-mediated nucleocytoplasmic shuttling of HuR","volume":"20","author":"Shatat","year":"2024","journal-title":"Purinergic Signal"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"9408","DOI":"10.1200\/JCO.2005.01.5594","article-title":"Targeting the Cell Cycle: A New Approach to Cancer Therapy","volume":"23","author":"Schwartz","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.canlet.2009.06.021","article-title":"Bid integrates intrinsic and extrinsic signaling in apoptosis induced by \u03b1-tocopheryl succinate in human gastric carcinoma cells","volume":"288","author":"Zhao","year":"2010","journal-title":"Cancer Lett."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/nrc1736","article-title":"Promoting apoptosis as a strategy for cancer drug discovery","volume":"5","author":"Fesik","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cellsig.2013.11.028","article-title":"The role of cell signalling in the crosstalk between autophagy and apoptosis","volume":"26","author":"Booth","year":"2013","journal-title":"Cell Signal"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Park, S.Y., Kim, K.Y., Gwak, D.S., Shin, S.Y., Jun, D.Y., and Kim, Y.H. (2024). L-Cysteine mitigates ROS-induced apoptosis and neurocognitive deficits by protecting against endoplasmic reticulum stress and mitochondrial dysfunction in mouse neuronal cells. Biomed. Pharmacother., 180.","DOI":"10.1016\/j.biopha.2024.117538"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Maleki, F., Handali, S., and Rezaei, M. (2025). The role of mitochondrial dysfunction in the cytotoxic synergistic effect of gemcitabine and arsenic on breast cancer. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0312424"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Jing, Q., Zhou, C., Zhang, J., Zhang, P., Wu, Y., Zhou, J., Tong, X., Li, Y., Du, J., and Wang, Y. (2024). Role of reactive oxygen species in myelodysplastic syndromes. Cell Mol. Biol. Lett., 29.","DOI":"10.1186\/s11658-024-00570-0"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Sato-Nagaoka, Y., Suzuki, S., Suzuki, S., and Takahashi, S. (2024). Combination of triciribine and p38 MAPK inhibitor PD169316 enhances the differentiation effect on myeloid leukemia cells. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0312406"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Gao, D., Lv, Y., Hong, F., Wu, D., Wang, T., Gao, G., Lin, Z., Yang, R., Hu, J., and He, A. (2025). Peroxiredoxin 6 maintains mitochondrial homeostasis and promotes tumor progression through ROS\/JNK\/p38 MAPK signaling pathway in multiple myeloma. Sci. Rep., 15.","DOI":"10.1038\/s41598-024-84021-y"}],"container-title":["Current Issues in Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1467-3045\/47\/4\/253\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:11:41Z","timestamp":1760029901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1467-3045\/47\/4\/253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["cimb47040253"],"URL":"https:\/\/doi.org\/10.3390\/cimb47040253","relation":{},"ISSN":["1467-3045"],"issn-type":[{"type":"electronic","value":"1467-3045"}],"subject":[],"published":{"date-parts":[[2025,4,7]]}}}